Stay updated on Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial

Sign up to get notified when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov record for the KRYSTAL 2 study is displayed, including its treatment and study details, eligibility criteria, and U.S. locations. The record indicates the study is completed and is no longer recruiting participants.
    Difference
    58%
    Check dated 2026-11-08T15:09:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-01T16:17:46.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A banner announces NIH website updates and a transition in terminology from “Artificial Intelligence” to “Super Intelligence.”
    Difference
    1%
    Check dated 2026-10-25T16:24:40.000Z thumbnail image
  4. Check
    25 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-18T16:12:10.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1, while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T15:59:39.000Z thumbnail image
  6. Check
    52 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error instead of the usual study details, showing a generic error screen.
    Difference
    18%
    Check dated 2026-09-20T19:39:46.000Z thumbnail image

Stay in the know with updates to Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Adagrasib + TNO155 in Cancer: KRYSTAL 2 Clinical Trial page.